SVS PSO VQI Regional Meeting: Virginias Vascular Study Group
| Registration |
|---|
|
Purpose
The Society for Vascular Surgery Patient Safety Organization (SVS PSO) improves the quality, safety, effectiveness, and cost of vascular healthcare by collecting and exchanging information through regional quality improvement groups.
Professional Practice Gap
Each regional group is provided with benchmark reports to compare their center/region/national outcomes to focus on quality improvement to meet the mission of the SVS PSO. Some examples include metrics on:
- Length of stay (cost)
- Long-term follow-up of patients (quality)
- Clinical outcomes, such as mortality and stroke (quality/safety)
- Use of statins and antiplatelets to decrease mortality (effectiveness)
- Adherence to scientific guidelines to optimize patient care (quality/safety/effectiveness)
By reviewing their benchmarks during these bi-annual meetings, each site and region can focus quality improvement efforts to improve and track their success over time.
Learning Objectives
- Establish quality improvement goals for vascular patients and their centers using the Vascular Quality Initiative (VQI) regional reports.
- Interpret and compare each center's VQI results to regional and national benchmarked data.
- Learn, through group discussion, the VQI regional report results to improve the quality of vascular health care by monitoring measurable performance indicators, SVS PSO evidence-based research, and outcomes.
- Identify high-performing regional vascular centers to discuss variations in care and clinical practice patterns to improve outcomes and prompt quality improvement recommendations for vascular care patients.
- Share best practices/pathways of care.
Agenda
The agenda is in the local time zone.
Coming soon.
Accreditation Statements
- Coming soon.
![]() | ![]() |
Educational Grants
Thanks to the following company for the generous financial support of this continuing education activity.
- W.L. Gore & Associates, Inc.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Click here to view the disclosures.
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
Price
This is a private course, and registrations are not being accepted.

Facebook
X
LinkedIn
Forward
